Project Grant HT9425261E231
Award Date 9/1/26
Completion Date 8/31/30
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Los Angeles a $1.70 million Project Grant on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "The 3D Multiomic Determinants of Prostate Cancer Lethality." The three-year project, with completion targeted for May 31, 2029, will be performed at UCLA's Los Angeles campus and is expected to deliver investigator-initiated biomedical...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $799,999 Project Grant effective May 1, 2026, through April 30, 2030, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "From H & E to HRD: Linking Morphometry, Clinical, and Molecular Data for Drug Response Prediction," supports biomedical research designed to advance medical solutions for Service Members and the military population. This award represents...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $235,476 project grant to the University of California, Los Angeles (UCLA) Office of Research Administration on November 1, 2025, to develop new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer. The two-year award, which concludes October 31, 2027, is funded under the Military Medical Research and Development program (CFDA 12.420) and will be conducted at UCLA's Los Angeles, California facility....
- Federal Project Grant Summary The Defense Health Agency (DHA) awarded a $700,000 Project Grant to the University of California, Los Angeles (UCLA) effective June 1, 2026, through May 31, 2030, under the Military Medical Research and Development program (CFDA 12.420). The project, "Early Detection of Ovarian Cancer with cfDNA Methylome Sequencing and Protein Biomarkers," focuses on developing innovative diagnostic methodologies for early ovarian cancer detection. This award supports...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $528,641 Project Grant to the University of California, Los Angeles (UCLA) effective July 1, 2026, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports investigator-initiated biomedical research focusing on extracellular vesicles as biomarkers in non-Hodgkin's lymphoma (NHL). This research aligns with the DHA's broader mission to advance medical solutions...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $7.999 million to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2026, for a Phase 1 single-blind, placebo-controlled, dose escalation study evaluating the safety of AD-NP1, a humanized monoclonal antibody targeting human enpp1 (ectonucleotide pyrophosphatase/phosphodiesterase 1). The project, to be conducted at UCLA's Los Angeles...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- Federal Project Grant Award Summary The Defense Health Agency awarded the University of California, Los Angeles a $1.5M Project Grant on July 1, 2026, through the Military Medical Research and Development program (CFDA 12.420) to develop a personalized and actionable brain health prediction algorithm for post-9/11 warriors. The four-year award, with completion scheduled for June 30, 2030, supports biomedical research addressing Service Member health outcomes and conditions affecting the military...
- Federal Grant Award Summary The Defense Health Agency awarded UCLA a $1.7 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for a three-year project period (July 1, 2026–June 30, 2029). The project focuses on the functional evaluation and optimization of chimeric antigen receptor T (CAR-T) cells targeting prostate cancer through cell-cell interaction profiling using engineered nanovials. This research represents advanced biomedical science aimed at...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $590,625 Project Grant to the University of California, Los Angeles (UCLA) effective September 1, 2025, through August 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports a pilot study investigating dual immunotherapy targeting programmed cell death protein 1 (PD-1) and CD73 in combination with chemotherapy for patients with pancreatic adenocarcinoma, with particular focus on...